The dominance of mega-cap tech stocks in growth investing is changing as these companies no longer move in sync, increasing risks in passive index funds. Active management, such as the Capital Group Growth ETF (CGGR), can selectively invest in high-conviction growth opportunities beyond tech, including healthcare innovations in biopharma and industrial sectors like aerospace and AI infrastructure. This shift allows investors to diversify growth exposure and potentially enhance returns by focusing on structural pioneers rather than broad momentum plays. CGGR offers a flexible, actively managed growth strategy with a competitive expense ratio, aiming to outperform traditional growth indexes while managing concentration risks.
President Trump warned France of a potential trade war, threatening 100% tariffs on French wines if France does not repeal its 3% digital tax on US tech giants like Google and Apple. This tax targets the revenue of American tech companies and has rai...
The Magnificent Seven—Microsoft, Apple, Alphabet, Amazon, Meta, Nvidia, and Tesla—dominate major U.S. indexes like the S&P 500 and Nasdaq-100. Investors can now choose ETFs that either concentrate solely on these tech giants, like the Roundhill Magni...
The SPDR S&P 500 ETF (SPY) has returned about 314% over the past decade, outperforming quality-focused ETFs like Invesco S&P 500 Quality (SPHQ) and iShares MSCI USA Quality (QUAL), which returned slightly less. These quality ETFs screen for financial...
AI token spending is decreasing as the era of subsidies ends and billing based on actual compute usage becomes standard. This change reflects a maturing AI market where pricing now balances supply, demand, and resource allocation more efficiently. Co...
The Dan Ives Wedbush AI Revolution ETF (IVES) has delivered a 17% gain year-to-date as of June 9, 2026, outperforming the S&P 500's 8% gain despite a recent 11% drop in one week. The fund's concentrated portfolio focuses on leading AI infrastructure ...
